Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Prepaid Assets: 2016-2024

Historic Prepaid Assets for Akebia Therapeutics (AKBA) over the last 9 years, with Dec 2024 value amounting to $11.3 million.

  • Akebia Therapeutics' Prepaid Assets fell 47.72% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year decrease of 47.72%. This contributed to the annual value of $11.3 million for FY2024, which is 43.93% down from last year.
  • According to the latest figures from FY2024, Akebia Therapeutics' Prepaid Assets is $11.3 million, which was down 43.93% from $20.2 million recorded in FY2023.
  • Over the past 5 years, Akebia Therapeutics' Prepaid Assets peaked at $33.1 million during FY2021, and registered a low of $11.3 million during FY2024.
  • Over the past 3 years, Akebia Therapeutics' median Prepaid Assets value was $20.2 million (recorded in 2023), while the average stood at $21.5 million.
  • As far as peak fluctuations go, Akebia Therapeutics' Prepaid Assets skyrocketed by 124.52% in 2020, and later tumbled by 43.93% in 2024.
  • Over the past 5 years, Akebia Therapeutics' Prepaid Assets (Yearly) stood at $14.9 million in 2020, then surged by 122.76% to $33.1 million in 2021, then fell by 0.83% to $32.9 million in 2022, then plummeted by 38.40% to $20.2 million in 2023, then tumbled by 43.93% to $11.3 million in 2024.